Reduced Cost of Operation and Increased Production Capacity to Fuel Growth of Pharmaceutical Continuous Manufacturing Market

Pharmaceutical continuous manufacturing requires less manual intervention and are thus gaining popularity. Using this technology, active ingredients are produced in compact and closed units, leveraging automation. Pharmaceutical continuous manufacturing helps in bringing about continued utilization of production capacity, which in turn improves yield, decrease fluctuations in the production process, and therefore results in reduced cost of operation. The advantages of this manufacturing process are increasingly being realized and this leading to rapid adoption of pharmaceutical continuous manufacturing, boosting its market worldwide. A leading market research firm Transparency Market Research (TMR) estimates that the global pharmaceutical continuous manufacturing market will rise from US$1.74 bn in 2016 to be worth US$3.693 bn by 2025, exhibiting a CAGR of 8.8% from 2017 to 2025.

The expert market analysts from TMR answer three important questions pertaining to this market in the following blog post:

Q. What are the factors driving the growth of the global pharmaceutical continuous manufacturing market?

The superior development speed of pharmaceutical continuous manufacturing technology is one of the key reasons boosting their adoption. This technology ensures enhanced process safety when handling hazardous chemicals. Pharmaceutical continuous manufacturing technology also gives an opportunity to perform reactions which cannot be done in batch processing. All these factors are anticipated to fuel the growth of this market across the globe. The growing incidences of various diseases and thus, the heightened demand for treatment are also expected to drive the growth prospects of this market. pharmaceutical continuous manufacturing technology is slated to succeed on account of the maturing of a mix of sophisticated technologies which is resulting in automation, better equipment and accurate monitoring.

Q. Which region is anticipated to emerge most attractive in the pharmaceutical continuous manufacturing market in the years to come?

Of the key geographical areas such as Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa, Europe is currently leading with maximum shares. Europe accounted for over 35% of the total market in 2016 on account of the escalating demand for superior technology from contract manufacturing organizations and pharmaceutical companies. It is also estimated that Europe will continue to lead and hold its position in the market for the years to come. In addition to this, the European market for pharmaceutical continuous manufacturing will expand at a rapid pace and be the fastest growing regional market too. The availability of advanced technologies and increasing number of technology providers are expected to be key reasons for the growth of this market.

Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20840

Q. Which application segment is leading in the global pharmaceutical continuous manufacturing market?

Of the key application segments of the global pharmaceutical continuous manufacturing market such as dry powders, biologics, and active pharmaceutical ingredients, the market for biologics is leading. In the year 2016, the biologics segment accounted for over 35.3% of the market. The pharmaceutical ingredients segment was in second position in 2016. This trend is likely to continue in the coming years. 

0 comments:

Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports